Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
5(100.0%)
5Total
N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06131671Not ApplicableCompleted

Whole-body Electrostimulation on Functional Mobility and Quality of Life in the Elderly

Role: collaborator

NCT06502522Not ApplicableNot Yet Recruiting

Effects of Whole-body Electrostimulation on Patients With Chronic Kidney Disease

Role: collaborator

NCT06025643Not ApplicableUnknown

Effects of Electrical Nervous Stimulation Transcutaneous in Hypertensive Patients

Role: collaborator

NCT05124756Not ApplicableUnknown

Effects of Bioelectric Stimulation in Patients With Non-Dialysis Dependent Chronic Kidney Disease

Role: collaborator

NCT04608422Not ApplicableUnknown

Bioeletric Stimulation in Patients With Chronic Kidney Failure

Role: collaborator

All 5 trials loaded